The REal Life EVidence AssessmeNt Tool (RELEVANT): development of a novel quality assurance asset to rate observational comparative effectiveness research studies
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Campbell, Jonathan D.
Papadopoulos, Nikolaos G.
van Ganse, Eric
van den Berge, Maarten
Funding for this research was provided by:
European Academy of Allergy and Clinical Immunology
Text and Data Mining valid from 2019-03-27
5 December 2018
20 February 2019
27 March 2019